Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression

Paul J. Hampel, MD, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Wei Ding, MD PhD, Eli Muchtar, MD, Saad S. Kenderian, MD, Yucai Wang, MD PhD, Amber Koehler, PA-C, MS, Amie Fonder, PA-C, MS, Jose F. Leis, MD PhD, Susan M. Schwager, Daniel L. Van Dyke, PhD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD

Blood (2019) 134 (Supplement_1): 3050.

https://doi.org/10.1182/blood-2019-125411

Published: 2019

Journal Articles

The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis

William J Archibald, MDCPA, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Curtis A. Hanson, MD, Wei Ding, MD PhD, Amber Koehler, PA-C, MS, Eli Muchtar, MD, Suzanne R. Hayman, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Yucai Wang, MD PhD, Amie Fonder, PA-C, MS, Min Shi, MD PhD, Daniel L. Van Dyke, PhD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD

Blood (2019) 134 (Supplement_1): 3037.

https://doi.org/10.1182/blood-2019-131154

Published: 2019

Journal Articles

Relapses after Achieving EFS24 in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Yucai Wang, MD, Umar Farooq, MD, Brian K. Link, MD, Mehrdad Hefazi, MD, Cristine Allmer, BS, Matthew J. Maurer, MS, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Stephen M. Ansell, MD PhD, James R. Cerhan, MD PhD, Grzegorz S. Nowakowski, MD

Blood (2018) 132 (Supplement 1): 454.

https://doi.org/10.1182/blood-2018-99-113213

Published: 2018

Journal Articles

Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation

Yucai Wang, MD, Marcella Tschautscher, MD, Kari G. Chaffee, MS, Timothy G. Call, MD, Jose F. Leis, MD PhD, Saad S. Kenderian, MD, Neil E. Kay, MD, Eli Muchtar, MD, Daniel L. Van Dyke, PhD, Susan M. Schwager, Susan L. Slager, PhD, Sameer A. Parikh, MD, Wei Ding, MD PhD

Blood (2018) 132 (Supplement 1): 1857.

https://doi.org/10.1182/blood-2018-99-113127

Published: 2018

Journal Articles

Bortezomib-Based Consolidation/Maintenance Therapy for Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials

Shijia Zhang, MD PhD, Yucai Wang, MD, Yvonne Datta, MD, Veronika Bachanova, MD PhD, Sarah Cooley, MD

Blood (2018) 132 (Supplement 1): 3293.

https://doi.org/10.1182/blood-2018-99-113533

Published: 2018

Journal Articles

Second Primary Malignancies in Patients with Non-Hodgkin Lymphoma

Yucai Wang, MD, Yanru Wang, MD PhD, Gita Thanarajasingam, MD, Carrie A Thompson, MD, Thomas M Habermann, MD, Grzegorz S Nowakowski, MD, Michael Wang, BS

Blood (2017) 130 (Supplement 1): 2152.

https://doi.org/10.1182/blood.V130.Suppl_1.2152.2152

Published: 2017

Journal Articles

Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma with 9p24.1 Copy Number Alterations

Yucai Wang, MD, Kerstin Wenzl, PhD, Matthew J Maurer, MS, Yan W Asmann, PhD, Susan L Slager, PhD, Thomas E Witzig, MD, Stephen M Ansell, MD PhD, Andrew L Feldman, MD, Brian K Link, MD, Grzegorz S Nowakowski, MD, James R. Cerhan, MD PhD, Anne J Novak, PhD

Blood (2017) 130 (Supplement 1): 196.

https://doi.org/10.1182/blood.V130.Suppl_1.196.196

Published: 2017

Journal Articles

A Single Institution Retrospective Review of Characteristics and Outcomes of Patients Requiring Chronic Dose Reduction of TKIs Given As Front-Line Therapy for Chronic Phase CML

Jamie L. Koprivnikar, MD, James K. McCloskey, MD, Yucai Wang, MD PhD, Genique Stanislaus, ANP, Stuart L. Goldberg, MD, Stefan Faderl, MD

Blood (2015) 126 (23): 5171.

https://doi.org/10.1182/blood.V126.23.5171.5171

Published: 2015

Journal Articles

Lenalidomide Plus Rituximab for Relapsed or Refractory Diffuse Large B-Cell, Follicular and Transformed Lymphoma: Final Data Analysis of a Phase 2 Trial

Blood (2015) 126 (23): 3969.

https://doi.org/10.1182/blood.V126.23.3969.3969

Published: 2015

Journal Articles

Vorinostat in Combination with Lenalidomide (L) and Dexamethasone (d) in Multiple Myeloma Patients Refractory to Previous Lenalidomide-Containing Regimens: Results of a Phase IIb Trial

Larysa Sanchez, MD, Yucai Wang, MD PhD, Laura McBride, RN, BSN, OCN, CCRP, Elizabeth Bilotti, MSN, David H. Vesole, MD, Joshua Richter, MD, Noa Biran, MD, Palka Anand, Kristin Ivanovski, Ann McNeill, ANP, David Siegel, MD PhD

Blood (2015) 126 (23): 4264.

https://doi.org/10.1182/blood.V126.23.4264.4264

Published: 2015

Journal Articles

Efficacy and Safety of Single-Agent Ruxolitinib Therapy for Myelofibrosis and Polycythemia Vera: A Meta-Analysis

Shijia Zhang, MD PhD, Yucai Wang, MD PhD, Larysa Sanchez, MD, Narjust Duma, MD, Victor Chang, MD

Blood (2015) 126 (23): 1622.

https://doi.org/10.1182/blood.V126.23.1622.1622

Published: 2015

Journal Articles

In-Hospital Complications and Mortality after Autologous Peripheral Blood Stem Cell Transplantation in Older Vs. Younger Multiple Myeloma Patients: An Analysis of the National Inpatient Sample

Larysa Sanchez, MD, Michael Sylvester, Yucai Wang, MD PhD, Shijia Zhang, MD PhD, Jean Eloy, MD FACS, Neil Kothari, MD, Victor Chang, MD

Blood (2015) 126 (23): 1783.

https://doi.org/10.1182/blood.V126.23.1783.1783

Published: 2015

Journal Articles

Outcomes of Salvage Stem Cell Transplantation in Hodgkin Lymphoma in a Single Institution in the Modern Era

Tatyana Feldman, MD, Larysa Sanchez, MD, Lina Starovoitova, BS, Ewelina Protomastro, MS, Yucai Wang, MD PhD, Neil Shah, MD, Michele L. Donato, MD, Scott D. Rowley, MD FACP, David H. Vesole, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Andre Goy, MD MS

Blood (2015) 126 (23): 5500.

https://doi.org/10.1182/blood.V126.23.5500.5500

Published: 2015

Journal Articles

Bortezomib-Containing Regimens for Multiple Myeloma Maintenance Therapy: a Meta-Analysis

Yucai Wang, MD PhD, Wenwen Zhang, MD, Fang Yang, MD, Xiaoxiang Guan, MD PhD, Neil Kothari, MD, Victor Chang, MD, Michael Wang, MD

Blood (2014) 124 (21): 3473.

https://doi.org/10.1182/blood.V124.21.3473.3473

Published: 2014

Journal Articles

The Efficacy and Safety of Immunomodulatory Drugs in Multiple Myeloma Maintenance Therapy: Results of a Meta-Analysis

Yucai Wang, MD PhD, Fang Yang, MD, Wenwen Zhang, MD, Xiaoxiang Guan, MD PhD, Neil Kothari, MD, Victor Chang, MD, Michael Wang, MD

Blood (2014) 124 (21): 3477.

https://doi.org/10.1182/blood.V124.21.3477.3477

Published: 2014

NARROW

BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression

The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis

Relapses after Achieving EFS24 in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation

Bortezomib-Based Consolidation/Maintenance Therapy for Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials

Second Primary Malignancies in Patients with Non-Hodgkin Lymphoma

Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma with 9p24.1 Copy Number Alterations

A Single Institution Retrospective Review of Characteristics and Outcomes of Patients Requiring Chronic Dose Reduction of TKIs Given As Front-Line Therapy for Chronic Phase CML

Lenalidomide Plus Rituximab for Relapsed or Refractory Diffuse Large B-Cell, Follicular and Transformed Lymphoma: Final Data Analysis of a Phase 2 Trial

Vorinostat in Combination with Lenalidomide (L) and Dexamethasone (d) in Multiple Myeloma Patients Refractory to Previous Lenalidomide-Containing Regimens: Results of a Phase IIb Trial

Efficacy and Safety of Single-Agent Ruxolitinib Therapy for Myelofibrosis and Polycythemia Vera: A Meta-Analysis

In-Hospital Complications and Mortality after Autologous Peripheral Blood Stem Cell Transplantation in Older Vs. Younger Multiple Myeloma Patients: An Analysis of the National Inpatient Sample

Outcomes of Salvage Stem Cell Transplantation in Hodgkin Lymphoma in a Single Institution in the Modern Era

Bortezomib-Containing Regimens for Multiple Myeloma Maintenance Therapy: a Meta-Analysis

The Efficacy and Safety of Immunomodulatory Drugs in Multiple Myeloma Maintenance Therapy: Results of a Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only